The BACES score, which stands for BMI, age, cavity presence, erythrocyte sedimentation rate, and sex, is linked to clinical treatment outcomes in Mycobacterium avium complex lung disease. This score can predict clinical improvement and help clinicians make treatment decisions for patients with the disease. A retrospective cohort study found that patients with higher BACES scores had lower rates of clinical improvement/stability and overall clinical-radiological improvement-stability response. The study also noted that the BACES score was not significant in predicting worsening radiological response rates or sputum culture persistence rate. Larger, prospective studies are needed to validate these findings and improve understanding of disease progression in these patients.
Source link
BACES score linked to clinical treatment outcomes in M. avium complex lung disease
